Compare · APT vs ZBH
APT vs ZBH
Side-by-side comparison of Alpha Pro Tech Ltd. (APT) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APT and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $25.25B, about 439.8x APT ($57.4M).
- ZBH has hit the wire 2 times in the past 4 weeks while APT has been quiet.
- ZBH has more recent analyst coverage (25 ratings vs 0 for APT).
- Company
- Alpha Pro Tech Ltd.
- Zimmer Biomet Holdings Inc.
- Price
- $4.62+2.67%
- $91.33-1.18%
- Market cap
- $57.4M
- $25.25B
- 1M return
- +0.87%
- -
- 1Y return
- +4.52%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- AMEX
- NYSE
- IPO
- 2000
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 25
Alpha Pro Tech Ltd.
Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through two segments, Disposable Protective Apparel and Building Supply. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap, synthetic roof underlayment, and other woven materials. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites; and pharmaceutical markets. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest APT
- Amendment: SEC Form SCHEDULE 13G/A filed by Alpha Pro Tech Ltd.
- SEC Form 4 filed by Alpha Pro Tech Ltd.
- SEC Form 10-K filed by Alpha Pro Tech Ltd.
- SEC Form 8-K filed by Alpha Pro Tech Ltd.
- Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
- CEO AND PRESIDENT Hoffman Lloyd was granted 12,425 shares, increasing direct ownership by 5% to 255,515 units (SEC Form 4)
- Director Buchan James sold $21,851 worth of shares (4,740 units at $4.61), decreasing direct ownership by 46% to 5,615 units (SEC Form 4)
- SEC Form 10-Q filed by Alpha Pro Tech Ltd.
- Alpha Pro Tech Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Alpha Pro Tech, Ltd. Announces Third Quarter 2025 Financial Results
Latest ZBH
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- SEC Form 4 filed by Noor Jehanzeb
- SEC Form 4 filed by Jafry Syed A.
- SEC Form 4 filed by Kolli Sreelakshmi
- SEC Form 4 filed by Shapiro Louis
- SEC Form 4 filed by Hilado Maria Teresa
- SEC Form 4 filed by Higgins Arthur J
- SEC Form 4 filed by Kurdikar Devdatt
- SEC Form 4 filed by Hagemann Robert